EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Select category

ANNOUNCEMENTS SHAREHOLDER INFORMATION

Select time

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Date

Title

File

Times

2026-04-01

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2026

53

2026-03-31

NOTICE OF ANNUAL GENERAL MEETING

54

2026-03-31

FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, 26 MAY 2026 (or any adjournment thereof)

49

2026-03-31

PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING

42

2026-03-23

FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025

120

2026-03-23

ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025

134

2026-03-11

NOTICE OF BOARD MEETING

250

2026-03-03

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2026

269

2026-02-03

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2026

521

2026-01-15

VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE IN RELATION TO EXCLUSIVE DISTRIBUTION AGREEMENT WITH OSTEOPORE

679

2026-01-09

INSIDE INFORMATION APPROVAL TO COMMERCIALISE MULTI-DOSE SODIUM HYALURONATE EYE DROPS (0.3%) IN THE PRC

685

2026-01-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2025

720

2025-12-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2025

858

2025-11-04

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2025

898

2025-10-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2025

1034

2025-09-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025

1147

2025-08-26

INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2025

1198

2025-08-26

INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025

1408

2025-08-14

NOTICE OF BOARD MEETING

1125

2025-08-13

BIOLOGICS LICENSE APPLICATION ACCEPTED FOR THE LICENSED PRODUCT FOR THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

1117

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT